Vimarsana
Biggest News Aggregation in the World

Page 2 - Endothelial Dysfunction News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Endothelial Dysfunction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Endothelial Dysfunction Today - Breaking & Trending Today

Here are 4 reasons to include tree nuts in your diet - Vimarsana News

Here are 4 reasons to include tree nuts in your diet

Tree nuts have been part of the human diet since ancient times. Consuming these small yet nutrition-packed superfoods is encouraged and even promoted in many dietary guidelines worldwide because [...]

Pathophysiological mechanisms of COVID-19-related endothelial dysfunction and potential therapies - Vimarsana News

Pathophysiological mechanisms of COVID-19-related endothelial dysfunction and potential therapies

Researchers discussed the pathophysiological mechanisms of endothelial dysfunction associated with severe coronavirus disease 2019 (COVID-19) and commented on the potential therapeutic strategies to treat endothelial damage and coagulopathy related to COVID-19.

Blueberries can Lower High BP and Cut Heart Disease Risk - Vimarsana News

Blueberries can Lower High BP and Cut Heart Disease Risk

Blueberries can lower the risk of heart disease in post-menopausal women with high blood pressure.

Biomarker-guided trial opens new avenues for personalised medicine in COVID-19 - Vimarsana News

Biomarker-guided trial opens new avenues for personalised medicine in COVID-19

A multi-centre study led by the University Hospital Hamburg-Eppendorf (UKE) is evaluating one of the first personalised approaches for moderate to sever...

SphingoTec GmbH: Biomarker-Guided Trial Led by University Hospital Hamburg-Eppendorf Opens New Avenues for Personalized Medicine in COVID-19 - Vimarsana News

SphingoTec GmbH: Biomarker-Guided Trial Led by University Hospital Hamburg-Eppendorf Opens New Avenues for Personalized Medicine in COVID-19

A multi-center study led by UKE is evaluating one of the first personalized approaches for moderate to severe COVID-19 patients.The innovative biomarkers bio-ADM and DPP3 are guiding the enrollment of